Francois Cornu, president of Eurofins Biomnis, and Gautier Decock, managing director of Eurofins BioPharma Product Testing in France and Belgium, come together to shed light on the company’s unique decentralized business model which incorporates CRO and diagnostic testing services. They go on to discuss the rationale behind this strategy and how Eurofins has gone on to become a leading player in both of these business activities.
We invest heavily into our technology and systems to best accelerate our clients’ projects – Eurofins understands that time to market is critical, no matter the size of the organization
